Date: 2014 / Author/Creator: Rhode, Peter R - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Date 2014 Author/Creator Rhode, Peter R

1. CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma. (6th November 2014)

Authors:: Margolin, Kim; Wong, Hing C; Morishima, Chihiro; Hernandez, Liza; Ernstoff, Marc; Rhode, Peter R; Waldmann, Thomas A
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 2(2014)Supplement 3
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models. (6th November 2014)

Authors:: Xu, Wenxin; Marcus, Warren D; Rhode, Peter R; Wong, Hing C
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 2(2014)Supplement 3
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma. (6th November 2014)

Authors:: Liu, Bai; Kong, Lin; Marcus, Warren D; Chen, Xiaoyue; Han, Kaiping; Rhode, Peter R; Wong, Hing C
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 2(2014)Supplement 3
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Novel antitumor mechanism-of-action of an IL-2 fusion protein mediated by tumor associated macrophage repolarization and innate-like CD8+ memory T cells. (6th November 2014)

Authors:: Xu, Wenxin; Egan, Jack O; Liu, Bai; Chen, Xiaoyue; You, Lijing; Han, Kaiping; Marcus, Warren D; Kong, Lin; Jones, Monica; Jeng, Emily K; Rhode, Peter R; Wong, Hing C
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 2(2014)Supplement 3
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas. (6th November 2014)

Authors:: Rosario, Maximillian; Liu, Bai; Kong, Lin; Schneider, Stephanie E; Jeng, Emily K; Rhode, Peter R; Wong, Hing C; Fehniger, Todd A
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 2(2014)Supplement 3
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗